Rare heart disease drug reduces risk of death by 30% in study | CredoWeb

Articol

Rare heart disease drug reduces risk of death by 30% in study

Rare heart disease drug reduces risk of death by 30% in study

Farmacie Cardiologie

Pfizer heart disease tafamidis transthyretin amyloid cardiomyopathy mortality

Partajați:

Comentarii